Kahn Brothers Group Holdings – 2026 Q1
Explore the latest portfolio disclosure for Kahn Brothers Group, with insights into sector exposure, position sizes, and overall investment structure for 2026 Q1.
The latest 2026 Q1 filing shows that Kahn Brothers Group maintains its largest exposure in Unclassified Sector, which represents approximately 25.62% of the portfolio. This sector forms the core of Kahn Brothers Group's investment stance during this reporting period.
Additional major allocations include Financial Services (about 17.23%) and Healthcare (approximately 16.65%) , reflecting how Kahn Brothers Group diversifies beyond its primary sector focus.
These sector weightings provide a clear view into Kahn Brothers Group's positioning and conviction areas for the 2026 Q1 quarter.
Breakdown by Sector
| Symbol | Shares | Reported Price(USD) | Action | Change % | Portfolio Weight | Position Value | Filing Period |
|---|---|---|---|---|---|---|---|
| C | 840,897 | $113.41 | Reduced | -4.04% | 16.91% | $95.37M | 2026 Q1 |
| BAYRY | 6,513,893 | $11.48 | Reduced | -3.56% | 13.26% | $74.78M | 2026 Q1 |
| FLG | 4,083,618 | $13.17 | Reduced | -2.24% | 9.54% | $53.78M | 2026 Q1 |
| DIS | 378,909 | $96.38 | Reduced | -3.92% | 6.48% | $36.52M | 2026 Q1 |
| GOOG | 122,029 | $286.86 | Reduced | -9.89% | 6.21% | $35.01M | 2026 Q1 |
| SEB | 5,871 | $5654.06 | Reduced | -19.41% | 5.89% | $33.19M | 2026 Q1 |
| OGN | 5,536,993 | $5.99 | Increased | 52.56% | 5.88% | $33.17M | 2026 Q1 |
| BP | 622,256 | $47 | Reduced | -40.08% | 5.19% | $29.25M | 2026 Q1 |
| MRK | 227,288 | $120.29 | Reduced | -47.15% | 4.85% | $27.34M | 2026 Q1 |
| Z | 545,212 | $41.38 | Buy | 100.00% | 4.00% | $22.56M | 2026 Q1 |
| SEG | 893,227 | $21.48 | Increased | 52.38% | 3.40% | $19.19M | 2026 Q1 |
| PTEN | 1,690,156 | $10.83 | Reduced | -2.98% | 3.25% | $18.3M | 2026 Q1 |
| IDT | 372,566 | $49.1 | Reduced | -4.96% | 3.24% | $18.29M | 2026 Q1 |
| PFE | 484,733 | $28.08 | Reduced | -12.50% | 2.41% | $13.61M | 2026 Q1 |
| MBI | 2,056,434 | $5.91 | Increased | 99.89% | 2.15% | $12.15M | 2026 Q1 |
| BMY | 170,381 | $60.65 | Reduced | -15.73% | 1.83% | $10.33M | 2026 Q1 |
| GSK | 160,982 | $55.19 | Reduced | -9.91% | 1.58% | $8.88M | 2026 Q1 |
| XOM | 18,255 | $169.65 | Reduced | -9.70% | 0.55% | $3.1M | 2026 Q1 |
| GNE | 175,011 | $14.14 | Reduced | -8.04% | 0.44% | $2.47M | 2026 Q1 |
| NVS | 13,386 | $152.77 | Reduced | -2.13% | 0.36% | $2.04M | 2026 Q1 |
| FRFHF | 1,018 | $1698.43 | No Change | No Change | 0.31% | $1.73M | 2026 Q1 |
| CSX | 36,481 | $41.06 | Reduced | -2.80% | 0.27% | $1.5M | 2026 Q1 |
| FBAK | 4,920 | $298.98 | No Change | No Change | 0.26% | $1.47M | 2026 Q1 |
| TRMLF | 26,959 | $47.7 | No Change | No Change | 0.23% | $1.29M | 2026 Q1 |
| JPM | 2,818 | $294.18 | Reduced | -18.74% | 0.15% | $829K | 2026 Q1 |